MassMutual Private Wealth & Trust’s Filana Therapeutics FLNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-29
Closed -$68 2470
2024
Q4
$68 Hold
29
﹤0.01% 2294
2024
Q3
$853 Buy
+29
New +$668 ﹤0.01% 1889
2023
Q1
Sell
-10
Closed 1877
2022
Q4
$0 Hold
10
﹤0.01% 1827
2022
Q3
$0 Buy
+10
New +$270 ﹤0.01% 1786
2022
Q2
Sell
-13
Closed 1689
2022
Q1
$0 Buy
+13
New +$551 ﹤0.01% 1620

Other funds holding FLNA

MassMutual Private Wealth & Trust's FLNA Position: Q1 2025 in Review

MassMutual Private Wealth & Trust sold out of Filana Therapeutics (FLNA) in Q1 2025, closing a stake of 29 shares — an estimated $68 sold.

MassMutual Private Wealth & Trust first reported a position in FLNA in Q1 2022 and held it in 5 quarters. The position peaked at $853 in Q3 2024. 117 funds tracked by Wall St. Rank hold FLNA as of Q1 2025.

  • MassMutual Private Wealth & Trust reported no remaining Filana Therapeutics position as of Q1 2025 after selling out during the quarter.
  • MassMutual Private Wealth & Trust sold 29 Filana Therapeutics shares in Q1 2025, an estimated $68.
  • MassMutual Private Wealth & Trust first reported a position in Filana Therapeutics in Q1 2022 and held it in 5 quarters.
  • MassMutual Private Wealth & Trust's Filana Therapeutics position peaked at $853 in Q3 2024.
  • 117 funds tracked by Wall St. Rank held Filana Therapeutics as of Q1 2025.

Based on MassMutual Private Wealth & Trust's 13F filing for Q1 2025, filed 1 Apr 2025.